GLP-1 Agonist Use Leads to Earlier Return of Bowel Function Following Lumbar Fusion

Dec 16, 2025Spine

GLP-1 Agonist Use Linked to Faster Recovery of Bowel Function After Lower Back Fusion Surgery

AI simplified

Abstract

Chronic GLP-1 agonist use is associated with a quicker return of bowel function after lumbar fusion surgery, averaging 1.35 days compared to 1.90 days for non-users.

  • 57 patients used GLP-1 agonists preoperatively, while 60 did not.
  • Patients on GLP-1 agonists were more likely to be female and had a higher average body mass index.
  • No significant differences were found in discharge disposition, length of hospital stay, or complications between the two groups.
  • There were no differences in patient-reported outcome measures after surgery for both groups.
  • GLP-1 agonist use independently reduced the time to return of bowel function, with a rate ratio of 0.69.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free